The Medicinal Chemistry of Cyanidin and its Glycoside Derivatives: Focus on the Antiproliferative and Potential Anticancer Activity
Planta Medica · 01.10.2025 · 91 (12) · 635-644
DOI: 10.1055/a-2634-4300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Planta Medica, erschienen am 01.10.2025. Verfasst von Abdur Rauf und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Swabi, Anbar, Khyber Pakhtunkhwa, Pakistan. Hauptthemen laut MEDLINE: Anthocyanins, Glycosides, Antineoplastic Agents, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Cyanidin and its glucosides are anthocyanins belonging to the class of flavonoid phytochemicals. These pigments give fruits and vegetables their typical reddish-purple nuance, and their peculiar chemical features result in a remarkable ability to neutralize reactive oxygen species and other mutagens. Thus, both cyanidin and its glycosides were proposed as candidates for chemoprevention, as anticancer agents, and as adjuvant therapies. Indeed, the compounds were investigated through various in vitro and in vivo models of colon, breast, kidney, prostate and liver cancer, and glioma. Cyanidin and its derivatives have been found to inhibit key signaling pathways, such as PI3K/Akt, MAPK, and NF-κB, which can reduce cancer cell growth, induce apoptosis, and suppress metastasis. In the first part of the review, the chemical properties of cyanidin and its glycoside analogues will be discussed. Then, an overview of in vitro evidence on activity will be presented, followed by a report on preclinical and clinical data together with comments on the mechanisms involved. Eventually, the aspect of pharmacokinetic properties, bioavailability, and formulation will be dissected. Overall, the review indicates that cyanidin and its derivatives could be effective anticancer agents but also calls for a deeper understanding of the molecular mechanisms underlying their bioactivity. Despite promising results, resolving issues like stability, absorption, and targeted distribution is crucial to maximize their therapeutic potential. More research is needed to develop innovative cyanidin-based formulations for efficient cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Swabi, Anbar, Khyber Pakhtunkhwa, Pakistan.
- Department of Medical Biochemistry, Abubakar Tafawa Balewa University, Bauchi, Nigeria.
- Department of Environmental and Public Health, College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
- Center of Biotechnology and Microbiology, University of Peshawar, Peshawar, KPK, Pakistan.
- Molecular Physiology Division, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.
- Oncology Division, Department of Biomedical and Clinical Science, Faculty of Medicine, Linköping University, Linköping, Sweden.
ORCID-Profile: Giovanni Ribaudo
Zitieren
APA
Rauf, A., Olatunde, A., Ajaj, R., Hafeez, N., Zaky, M. Y., Islam, M. R., Islam, M. M., & Ribaudo, G. (2025). The Medicinal Chemistry of Cyanidin and its Glycoside Derivatives: Focus on the Antiproliferative and Potential Anticancer Activity. Planta Medica, 91(12), 635-644. https://doi.org/10.1055/a-2634-4300
Vancouver
Rauf A, Olatunde A, Ajaj R, Hafeez N, Zaky MY, Islam MR, et al. The Medicinal Chemistry of Cyanidin and its Glycoside Derivatives: Focus on the Antiproliferative and Potential Anticancer Activity. Planta Medica. 2025;91(12):635-644. doi:10.1055/a-2634-4300
BibTeX
@article{Rauf2025,
author = {Rauf, Abdur and Olatunde, Ahmed and Ajaj, Rahaf and Hafeez, Nabia and Zaky, Mohamed Y and Islam, Md Rezaul and Islam, Md Mozahidul and Ribaudo, Giovanni},
title = {The Medicinal Chemistry of Cyanidin and its Glycoside Derivatives: Focus on the Antiproliferative and Potential Anticancer Activity},
journal = {Planta Medica},
year = {2025},
volume = {91},
number = {12},
pages = {635--644},
doi = {10.1055/a-2634-4300}
}
EUVIMED